ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,010, issued on Sept. 22, was assigned to First Tracks Biotherapeutics Inc. (San Diego).

"PD-1 agonist and method of using same" was invented by Marilyn Kehry (San Diego), Stephen Parmley (San Diego), Robert P. Morse (San Diego), Gregory N. Gold (San Diego), Janean Fisher (San Diego), Martin Edward Dahl (San Diego), Margaret Habash Marino (San Diego) and Rupal Kalapanda (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is a PD-1-binding agent comprising an immunoglobulin heavy chain polypeptide and immunoglobulin light chain polypeptide, as well as related compositions and methods for making and using same."

The patent was filed on...